Rhabdomyosarcoma is the most common soft tissue sarcoma in children. A phase II clinical trial is the first to show improved outcomes in rhabdomyosarcoma in 45 years.
Rhabdomyosarcoma is the most common soft tissue sarcoma in children. A phase II clinical trial is the first to show improved outcomes in rhabdomyosarcoma in 45 years.